HLS Therapeutics Debt 2024

HLS Therapeutics Aktienanalyse

What does HLS Therapeutics do?

HLS Therapeutics Inc. is a Canadian pharmaceutical company focused on the development and distribution of medical products in the North American market. It was founded in 2018 and is headquartered in Toronto, Canada. HLS Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding HLS Therapeutics's Debt Structure

HLS Therapeutics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing HLS Therapeutics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to HLS Therapeutics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in HLS Therapeutics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about HLS Therapeutics stock

What is the debt of HLS Therapeutics this year?

HLS Therapeutics has a debt level of 65.67 USD this year.

What was the debt of HLS Therapeutics compared to the previous year?

The debt of HLS Therapeutics has increased by -14.27% compared to the previous year dropped.

What are the consequences of high debt for investors in HLS Therapeutics?

High debt can pose a risk for investors of HLS Therapeutics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of HLS Therapeutics?

Low debt means that HLS Therapeutics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from HLS Therapeutics affect the company?

An increase in debt of HLS Therapeutics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of HLS Therapeutics affect the company?

A reduction in debt of HLS Therapeutics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of HLS Therapeutics?

Some factors that can influence the debt of HLS Therapeutics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of HLS Therapeutics so important for investors?

The debts of HLS Therapeutics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can HLS Therapeutics take to change the debt?

To change the debt, HLS Therapeutics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does HLS Therapeutics pay?

Over the past 12 months, HLS Therapeutics paid a dividend of 0.2 USD . This corresponds to a dividend yield of about 8.58 %. For the coming 12 months, HLS Therapeutics is expected to pay a dividend of 0.18 USD.

What is the dividend yield of HLS Therapeutics?

The current dividend yield of HLS Therapeutics is 8.58 %.

When does HLS Therapeutics pay dividends?

HLS Therapeutics pays a quarterly dividend. This is distributed in the months of August, November, February, May.

How secure is the dividend of HLS Therapeutics?

HLS Therapeutics paid dividends every year for the past 0 years.

What is the dividend of HLS Therapeutics?

For the upcoming 12 months, dividends amounting to 0.18 USD are expected. This corresponds to a dividend yield of 7.9 %.

In which sector is HLS Therapeutics located?

HLS Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von HLS Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of HLS Therapeutics from 6/15/2023 amounting to 0.05 USD, you needed to have the stock in your portfolio before the ex-date on 4/27/2023.

When did HLS Therapeutics pay the last dividend?

The last dividend was paid out on 6/15/2023.

What was the dividend of HLS Therapeutics in the year 2023?

In the year 2023, HLS Therapeutics distributed 0.2 USD as dividends.

In which currency does HLS Therapeutics pay out the dividend?

The dividends of HLS Therapeutics are distributed in USD.